Bristol Investigating Failed Plavix Settlement With Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb has begun an independent investigation into the company's failed negotiations with Apotex over Plavix, according to a statement posted by the company's board of directors on Bristol's website Aug. 17